Breast Cancer Clinical Trial

Excision Followed by Radiofrequency Ablation for Breast Cancer

Summary

The purpose of this study will be to evaluate, in a multi-center setting, the ability of radiofrequency ablation (RFA) of breast cancer lumpectomy sites to extend the "final" negative margin and consequently decrease the rates of re-operation. During the initial breast conservation procedure (lumpectomy), immediately following routine surgical resection of the tumor, radiofrequency energy (RFA) is applied to the wall (bed) of the fresh lumpectomy cavity, thus extending tumor free margin radially beyond the volume of the resected specimen.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patient is a female, ≥ 50 years of age
The tumor size is ≤ 3 cm (on pre-study radiologic OR clinical exam)
The tumor is unicentric and unilateral
The tumor is not involving the skin
Pathology confirms ductal in situ (DCIS) OR infiltrating ductal carcinoma (IDC), grade I-III
If tumor is IDC, pathology must be hormone receptor positive (ER+ and/or PR+)
Patient signs current written informed consent and HIPAA forms

Exclusion Criteria:

Patient is under 50 years of age
Patient is male
Tumor > 3 cm in diameter
Bilateral malignancy
Clinically positive lymph nodes
Tumor involving the skin
Pathology confirms invasive lobular carcinoma
Breast implants
Less than 2 years disease-free survival from previous breast cancer
Neoadjuvant chemotherapy or chemotherapy for another breast cancer within two years

Study is for people with:

Breast Cancer

Estimated Enrollment:

104

Study ID:

NCT01153035

Recruitment Status:

Active, not recruiting

Sponsor:

University of Arkansas

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 6 Locations for this study

See Locations Near You

University of Arizona
Tucson Arizona, 85704, United States
University of Arkansas for Medical Sciences
Little Rock Arkansas, 72205, United States
Sharp Oncology (Comprehensive Breast Care of San Diego)
San Diego California, 92123, United States
Comprehensive Breast Care of Denver
Denver Colorado, 80218, United States
The University of Kansas Cancer Center
Westwood Kansas, 66205, United States
Columbia
New York New York, 10032, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

104

Study ID:

NCT01153035

Recruitment Status:

Active, not recruiting

Sponsor:


University of Arkansas

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider